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Dietary flavonoid intake, especially berry flavonoids, has been associated with 
antioxidant functions and metal chelation in mechanistic studies. We examined the 
hypothesis that freeze-dried strawberries (FDS) improve antioxidant biomarkers in adults 
with abdominal adiposity and elevated serum lipids. In a randomized dose-response 
controlled trial, 60 volunteers [5 men and 55 women; age: 49 ± 10 years; BMI: 36 ± 5 
kg/m2 (mean±SD)] were assigned to one of the following arms: low dose FDS (LD-FDS) 
(25g/d), low dose control (LD-C), high dose FDS (HD-FDS) (50g/d), and high dose 
control (HD-C) beverages for 12 weeks. Control beverages were matched for calories and 
total fiber. Serum levels of trace elements and whole blood glutathione, and catalase 
activity were examined at screening (0 week) and after 12 weeks intervention. At 12 
weeks, glutathione levels were higher in HD-FDS vs. LD-FDS, as well as vs. HD-C, and 
catalase activity was lower in HD-FDS vs. baseline (all P<0.05). No differences were 
noted in serum trace elements following FDS intervention. Thus, dietary strawberries 
may selectively modulate antioxidant biomarkers that influence risk factors of chronic 
diseases.  
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CHAPTER I 
 
 
INTRODUCTION 
 
 
Cardiovascular disease (CVD) remains a significant public health concern and the leading cause 
of mortality in the US1. Several of the risk factors underlying CVD are modifiable by dietary and 
lifestyle factors, including those related to overweight/obesity and dyslipidemia2. Obesity and 
dyslipidemia have also been associated with elevated oxidative stress, reduced antioxidant status 
and consequently the initiation and progression of CVD3-6.  
Oxidative stress identifies a biological condition when the production of harmful reactive oxygen 
species (ROS) and the concentrations of intracellular and extracellular antioxidants are under 
imbalance7. An antioxidant is any substance that can delay or prevent oxidation of a particular 
substrate. Antioxidants help protect against oxidative stress7. 
Trace elements are vital for biochemical reactions necessary for cell survival and human health, 
though they constitute only <0.01% of our total body weight8. Trace minerals like selenium and 
zinc are essential in reducing oxidative stress, and in performing antioxidant functions, while iron 
and copper can behave as an oxidant8. Studies have shown typically higher levels of iron and 
copper, and lower levels of zinc and selenium in populations with obesity and dyslipidemia9-12. 
Cells protect themselves against oxidative stress by endogenous enzymatic antioxidants, 
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including superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPX), in a 
highly regulated endogenous defense system. These enzymes are important in reducing oxidative 
stress13. Trace elements are an integral component of antioxidant defense enzymes, such as the 
role of selenium in GPX, and that of copper and zinc in the antioxidant function of SOD8,14-16. 
Phytochemicals are plant-derived compounds that have gained attention for their protective 
effects against chronic diseases like CVD, cancer, osteoporosis, neurodegenerative diseases, and 
diabetes mellitus17. Strawberries are a popular berry fruit consumed in the US and previous 
clinical and observational studies show the role of strawberries in reducing CVD risks18-22. 
However, only a few studies have examined the role of dietary strawberries in modulating 
biomarkers of oxidative stress/antioxidant status, especially in participants with CVD risk factors, 
and this constitutes the scope of our current investigation. 
 
Purpose 
The purpose of this study is to identify the dose-dependent effects of a 12-week dietary 
strawberry supplementation on plasma trace elements and selected endogenous antioxidants in 
subjects with obesity and dyslipidemia. 
 
Hypotheses 
1. Consumption of freeze-dried strawberries (low vs. high dose) will affect plasma 
levels of trace elements, especially lower plasma iron, in obese individuals with 
above optimal serum lipids at 12 weeks when compared to baseline and their 
respective control groups. 
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2. Consumption of freeze-dried strawberries (low vs. high dose) will increase plasma 
levels of endogenous antioxidant catalase activity in obese individuals with above 
optimal serum lipids at 12 weeks when compared to baseline and their respective 
control groups. 
3. Consumption of freeze-dried strawberries (low vs. high dose) will increase whole 
blood levels of endogenous antioxidant glutathione in obese individuals with above 
optimal serum lipids at 12 weeks when compared to baseline and their respective 
control groups.  
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CHAPTER II 
 
 
REVIEW OF LITERATURE 
 
 
A. Cardiovascular disease, dyslipidemia, and obesity and associations with trace 
elements and antioxidant status 
 
i. Cardiovascular disease 
Cardiovascular disease (CVD) tragically takes a toll on much of the world’s population and 
remains the leading cause of mortality in the U.S.1 Several of the risk factors underlying CVD are 
modifiable by dietary and lifestyle practices. These modifiable risk factors include 
overweight/obesity, especially abdominal obesity; dyslipidemia (high triglycerides, low HDL 
cholesterol, high LDL cholesterol, and high total cholesterol) and smoking2. Globally, the 
prevalence of overweight and obesity has reached what we know to be an all-time high: over 1.6 
billion adults (20 years or older) are overweight and approximately 500 million within that 
category are also classified as obese2. In the US, 35.9% of adults over the age of 20 years are 
obese, while those who are overweight and including obesity make up 69.2% of adults aged 20+ 
years23. Dyslipidemia and hyperlipidemia, as strong CVD risk factors are prevalent in the 
developed countries, including the US2. Nearly one in six of Americans over 20 years of age have 
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high serum cholesterol levels – particularly high levels of serum LDL cholesterol – which is a 
major carrier of cholesterol and contributes to CVD24. High levels of HDL cholesterol and low 
levels of LDL cholesterol are desirable for cardiovascular health8. 
ii. Dyslipidemia 
Dyslipidemia is characterized by four types of lipid disorders: high triglycerides, high total 
cholesterol, high LDL cholesterol, and low HDL cholesterol concentrations25. One in three US 
adults have elevated cholesterol levels, while less than half of this population seeks treatment to 
manage the condition. The American Heart Association (AHA) recommends optimal total serum 
cholesterol as below 200 mg/dL, with LDL cholesterol levels less than 100 mg/dL and HDL 
cholesterol levels greater than 60 mg/dL. The AHA also recommends optimal triglyceride levels 
as below 150 mg/dL26.  
Several aspects of research have established the positive relationship between elevated lipids and 
CVD27,28,29. Dietary intakes of total fat, saturated fatty acids, cholesterol, and trans fats have been 
shown to have a positive correlation with CVD risks, mostly due to the hypercholesterolemic 
effect, and increases in LDL: HDL cholesterol ratios. Lipids such as monounsaturated fatty acids, 
polyunsaturated fatty acids, and omega-3 fatty acids show an inverse correlation with CVD 
risks30. Dietary and lifestyle factors like weight loss, reduction in fat intake, increased fiber 
intake, and increased physical activity have been shown to reduce CVD risks and improve 
cardiovascular health. 
iii. Obesity 
Obesity is a strong CVD risk factor and its incidence is observed similarly in younger and older 
age groups. More notably, significant evidence has shown that an obese child is likely to grow 
into an obese adult31-33. For this reason, obesity is a significant public health concern in the US. 
The morbidity related to the next generation of adults who are obese is predicted to become worse 
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than it is now33. Body mass index (BMI), generally used as an indicator of obesity, is a 
calculation using an individual’s height and weight to determine their weight classification. A 
BMI value 25 kg/m2 or higher categorizes the individual as overweight, while a BMI 30 kg/m2 or 
higher indicates that the individual is obese. Hip-to-waist ratio is also important in determining 
metabolic health by one’s size and weight34. 
Increased amounts of adipose tissue in obese subjects lead to increased non-esterified fatty acids, 
glycerol, hormones (such as leptin and insulin), and pro-inflammatory cytokines when compared 
to the non-obese individual35. Obesity and weight gain result in increased oxidative stress, often 
resulting from the dysregulation of adipokine secretion that occurs in adipose tissue5. This 
dysregulation of adipokine secretion over time can lead to chronic conditions related to obesity, 
including insulin resistance, type 2 diabetes mellitus, atherosclerosis, and CVD36,37.  
The abnormal adipokine secretion in obesity affects the functions of other tissues, like the liver, 
muscle, central nervous system, and vasculatures38. Identifying the effects of oxidative stress in 
obesity is important because adipokine secretion influences many vital metabolic processes, such 
as impaired carbohydrate and lipid metabolism, energy expenditure, inflammation, endothelial 
function, and blood coagulation. All of these conditions contribute to elevated CVD risks39. 
 
iv.  Oxidative stress 
 Oxidative stress identifies a biological condition when the production of ROS and the amounts of 
intracellular and extracellular antioxidants are under imbalance. While production of ROS is a 
normal metabolic process in living cells, the overproduction of ROS could lead to deleterious 
effects. Excessive oxidants mediate injury to cells or tissues and may lead to cell death by 
mechanisms of apoptosis and necrosis7. This damage may be caused by normal cellular 
metabolism, and by factors such as oxygen, light, free radicals, and metal ions, as well as the 
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aging process40. Endogenous oxidants like superoxide anion radical (O2-), hydrogen peroxide 
non-radical (H2O2), and hydroxyl radical (●OH) are products of normal aerobic respiration by 
mitochondria. Yet, chronic infections by bacteria, viruses, and parasites result in chronic 
inflammation, and thus lead to higher levels of these ROS40.  
Oxidative stress and obesity 
Obesity has been associated with elevated oxidative stress and is a well-established CVD risk 
factor3,4. Fat accumulation has been shown to be correlated with systemic oxidative stress in both 
animal and human models of oxidative stress5. In studies involving healthy obese subjects with 
no pronounced health abnormalities other than high BMI, findings have shown a positive 
correlation between BMI and oxidative stress41-44. Animal models of oxidative stress have also 
produced identical results correlating adiposity with lipid peroxidation45,46. 
Since obesity increases the mechanical and metabolic burden on the myocardium, myocardial 
oxygen consumption is increased and production of ROS is also increased due to increased 
mitochondrial respiration47. A study evaluating abdominal obesity in pigs fed a high-fat diet 
reported that early phases of abdominal obesity resulted in increased incidence of coronary 
endothelial dysfunction, as well as vascular oxidative stress, hypertension, and mild abnormalities 
of lipid profiles compared to controls. However, no systemic inflammation or oxidative stress 
was observed, indicating that early obesity-related abnormalities are localized in the vasculature 
and contributes to increased risk for CVD48.  
Oxidative stress related to obesity is also likely to be induced by other possible conditions 
associated with obesity, including dyslipidemia , hypertension, poor diet, hyperglycemia, low 
physical activity, and smoking49. 
Oxidative stress and dyslipidemia 
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Dyslipidemia has been shown to elevate oxidative damage, resulting in increased oxidative 
stress50. LDL cholesterol contains a large amount of polyunsaturated fatty acids which is 
susceptible to becoming oxidized lipid radicals6. ROS promptly inactivates vascular nitric oxide 
(necessary for inhibition of platelet function and is a vasorelaxant), and can increase risks for 
atherosclerosis and stroke. Fibrinogen activity is enhanced by ROS and reactive nitrogen species 
(RNS), resulting in accelerated clot formation and thrombosis38,51. Oxidation of LDL cholesterol 
promotes monocyte activation leading to transformation into foam cells, which are mediators of 
the chronic process of atherosclerosis 52.  
 
v. Antioxidants 
An antioxidant has been defined as “any substance that can delay or prevent oxidation of a 
particular substrate”53, or “any substance that, when present at low concentration compared to 
those of an oxidizable substrate, significantly delays or inhibits oxidation of that substrate”54. 
Antioxidants can be either enzymatic or non-enzymatic. They are reducing agents, or electron 
donors, that have the ability to reverse oxidation due to their nature of donating electrons and 
hydrogen ions8.  
Dietary or non-enzymatic antioxidants include micronutrients like vitamins A, C, and E, 
selenium, and zinc, as well as polyphenols like flavonoids, tannins, anthocyanins, and ellagic 
acid8,40,55-57. Food sources that contain high amounts of antioxidants include whole grains, 
vegetables, and fruits, particularly berries, and other yellow- and orange-colored fruits and 
vegetables. Among popular beverages, green tea and cocoa drinks also have noteworthy amounts 
of antioxidants58. These potent antioxidants have been shown to inhibit lipid oxidation and 
therefore reduce the likelihood for CVD and its risk factors59.  
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Furthermore, antioxidants prevent DNA and protein damage, which could lessen the likelihood of 
developing chronic diseases like diabetes mellitus, a risk factor for CVD55. Enzymatic 
antioxidants are an integral constituent of the cellular defense mechanisms such as superoxide 
dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPX). Low antioxidant status has 
been correlated with increased serum total cholesterol concentrations, while high plasma 
concentrations of antioxidants correlate with higher plasma HDL-cholesterol levels8. 
Vitamins as antioxidants  
Among all vitamins, A, C and E deserve special attention as dietary antioxidants. Vitamin A, or 
retinol, can be synthesized in the body from dietary carotenoids, especially α-carotene and β-
carotene. Orange and yellow vegetables, spinach, collards, and turnip greens are significant 
sources of β- and α-carotene. Retinol is a fat-soluble vitamin and will not be absorbed unless 
consumed with a fat-containing meal. Carotenoids in plants function as antioxidants and are 
quenchers of singlet oxygen, with lycopene being one of the most effective quenchers of this 
element18.  
Vitamin C, also known as ascorbate or ascorbic acid, is a water-soluble vitamin that is found in a 
variety or fruits and vegetables like papaya, oranges, broccoli, green peppers, grapefruit, and 
strawberries. This antioxidant is a reducing agent that is protective in aqueous solutions like in the 
blood and intracellular matrix. Ascorbate has a noteworthy reduction potential in that it will 
readily donate electrons to regenerate other antioxidants, such as vitamin E and glutathione. 
While vitamin C is known to be an antioxidant, it can also reduce transition metals like cupric 
ions (Cu2+) to cuprous (Cu3+) and ferric ions (Fe3+) to ferrous (Fe2+), while the vitamin itself is 
oxidized to a semidehydroascorbate radical. Ascorbic acid can later be regenerated by two 
semidehydroascorbate radicals to  produce two ascorbate molecules8.  
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Vitamin E has eight configurations, of which four are tocopherols and four are tocotrienols, and 
all contain the same phenolic functional group on a chromane ring and a phytyl side chain8. 
Vitamin E can be found in both plant and animal derived foods, including canola oil, olive oil, 
whole-grain cereals, and fatty tissues of animals. Vitamin E functions principally in maintaining 
the integrity of the cell membrane, where it protects cell damage by inhibiting peroxidation of 
phospholipids that make up the membrane. α-tocopherol is most effective in the ability to donate 
electrons, which act quickly to neutralize free radicals, like peroxyl radicals, thus reducing 
damage to the cell membrane8.  
 
vi. Trace elements: iron, zinc, copper, and selenium 
Trace elements (minerals) are vital for biochemical reactions necessary for cell survival and 
human health, though they constitute only <0.01% of our total body weight. Trace elements like 
selenium and zinc are essential in reducing oxidative stress, and in performing antioxidant 
functions, while iron and copper can behave as an oxidant8.  
Iron 
Iron in the body is primarily found in hemoglobin, but is also present in myoglobin, enzymes, 
blood, and in storage in much smaller amounts. Iron in the diet is found in either heme or 
nonheme form. Heme iron is mainly a component of animal products since it is present in 
hemoglobin and myoglobin. Nonheme is primarily present in plant foods like nuts, grains, tofu, 
fruits, and vegetables, but is also present in dairy products in smaller amounts8. Once released 
from the food components, most of the nonheme iron is present as ferric (Fe3+) iron in the 
stomach, while some of it may be reduced to ferrous (Fe2+) iron. Ferrous iron is absorbed in the 
small intestine by transporter binding at the brush border on the enterocyte; ferric state is reduced 
to ferrous state by ferrireductases and vitamin C in the intestine60,61. Ferric iron absorption 
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mechanisms are not well known, but an acidic environment is preferred and facilitation by 
chelation of iron with chelators or ligands helps solubilize ferric iron. Its absorption across the 
brush border requires membrane protein integrin, which is part of the paraferritin complex, also 
including mobilferrin and ferrireductase61,62.  
Chelators or ligands that bind with nonheme iron can either inhibit or enhance its absorption, part 
of which depends on the nature of the iron-chelate/ligand complex. Components in the diet that 
may enhance nonheme iron absorption include sugars, acids, meat, poultry, fish, and mucin, for 
each of these components act as chelators and can increase absorption of nonheme iron. Vitamin 
C acts as a reducing agent, forming a chelate with nonheme ferric iron in an acidic environment, 
and the chelate remains soluble in the small intestine which improves its absorption62. Factors in 
the diet that inhibit iron absorption include polyphenols, oxalic acid, phytates, calcium, calcium 
phosphate salts, and zinc. Polyphenols consumed with an iron-rich meal can reduce absorption of 
iron by 40-60%63. Phytates and oxalates bind to many minerals, and the resulting complexes are 
insoluble and poorly absorbed64. Calcium and phosphorus ingested in large amounts interact with 
iron absorption by chelate formation at the intestinal mucosa layer and can decrease absorption up 
to 70%. Zinc and iron may compete for the same transporters and negatively affect each other’s 
absorption65-67. 
During transport in the blood, iron in its oxidized ferric state is bound to protein transferrin which 
also acts as an antioxidant. If iron is left unbound, harmful free radicals can result. Iron can 
behave as a pro-oxidant as free ferrous iron can readily react with H2O2, producing a free 
hydroxyl radical that is extremely reactive and damaging to cells. The binding of iron to protein is 
equally important to prevent free iron that can be used by bacteria to grow and proliferate68. 
However, iron is also important in the antioxidant defense system, such as in CAT which has four 
heme groups and converts two molecules of H2O2 to water and molecular oxygen.. Thus, while 
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free iron can act as a pro-oxidant, iron as part of antioxidant enzymes plays a crucial role in 
alleviating oxidative stress69. 
Zinc 
Zinc is almost universally found as Zn2+, its divalent ion, and is complexed with amino acids in 
food sources like red meat, seafood, poultry, pork, and dairy products. Whole grains and leafy or 
root vegetables represent good plant sources of zinc, but have a lower zinc content and the zinc 
located in plants isn’t as efficiently absorbed as meat products70. Like iron, zinc must be 
hydrolyzed from its bound form with amino acids before absorption can take place. Zinc is 
absorbed into the intestinal cell by a carrier-mediated process and low zinc intakes are absorbed 
better than higher intakes. Passive diffusion and paracellular zinc absorption also may occur 
during periods of high zinc intake71,72. Zinc absorption can be enhanced or inhibited by chelators 
or ligands, depending on the absorbability of the chelate formed like in the case with iron73. Citric 
acid, prostaglandins, certain amino acids, pancreatic secretions, glutathione, tripeptides, and low 
zinc status tend to enhance zinc absorption. Absorption may be inhibited by phytate, oxalate or 
oxalic acid, polyphenols, folate, other divalent cations, and sometimes calcium8,64,74.  
 Zinc, as a vital trace mineral, is present along with copper as a structural constituent of SOD, 
which is an endogenous antioxidant enzyme that takes part in antioxidant defense roles by 
catalyzing superoxide O-2 radicals, into water and free molecular oxygen. Zinc is also known to 
be part of other enzyme systems essential for physiological functions. When zinc binds with 
protein thionein in the body, the complex is known as metallothionein. Although metallothionein 
serves as a storage site, it is also increased during states of stress and is known as an acute phase 
(reactant) protein.  This protein has been found to stabilize membranes, regulate zinc and copper 
metabolism, and detoxify heavy metals. More importantly, this protein functions as a radical 
scavenging antioxidant of, for example, hydroxyl radicals. Zinc may contribute to the antioxidant 
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protection of the structure of cell membranes by eliminating free radicals, as a structural 
component of metallothionein8,15,74,75. 
Copper 
Copper is present in either the cuprous state (Cu+) or cupric state (Cu2+) and is found in a wide 
variety of foods. Organ meats and shellfish are the richest sources, while plant sources high in 
this mineral include dried fruits, legumes, nuts, and seeds8. Most copper in foods is bound to 
amino acids and other organic components, which requires bound copper to be removed  before 
absorption can take place76. Hydrochloric acid and pepsin in the stomach facilitate the release of 
bound copper. The stomach absorbs some copper, but most absorption takes place at the brush 
border of the small intestine. While copper’s absorption process is not completely understood, it 
appears to be taken in by active carrier-mediated transporters as well as by passive diffusion. 
However, before absorption can occur, the copper ions must be reduced by copper reductase, 
stimulated by vitamin C. Copper status and available dietary copper influence the amount of 
copper that is absorbed in a given time. There are several enhancers of copper absorption, 
including amino acids, citric, gluconic, lactic, acetic, and malic acids. Yet, copper absorption can 
be inhibited by compounds such as phytate, zinc, iron, calcium, phosphorus, and a high pH 
environment77. 
Free copper, like iron, is typically bound to amino acids and glutathione, as free copper ions may 
damage cells by oxidizing reactions. More importantly, copper participates as an enzyme cofactor 
and allosteric component of enzymes, where in many functions copper will serve as an 
intermediate electron transfer78,79. Ceruloplasmin is a multifaceted copper-containing enzyme and 
antioxidant found in blood and bound to plasma membrane cell receptors. This glycoprotein 
oxidizes minerals like iron and manganese to bind to transferrin and is then transported to tissues. 
Ceruloplasmin also functions as a scavenger of oxygen radicals to protect cells and is a modulator 
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of inflammation80,81. SOD functions to catalyze removal of superoxide radicals where copper is 
reduced with the oxygen radical to generate molecular oxygen and then re-oxidized to hydrogen 
peroxide (H2O2). In absence of adequate SOD, superoxide radicals can damage unsaturated 
double bonds in cell membranes, fatty acids, and other cell molecules by formation of hydroxyl 
radicals. Peroxidation of cell membranes is found to be increased in copper deficiency8.  
Selenium 
Selenium is a nonmetal that exists in a variety of oxidation states. Concentrations of selenium in 
plant foods will vary greatly depending on soil selenium concentration in different regions of the 
world. Seafood is known to represent a better source of selenium except that it may be poorly 
absorbed due to mercury-selenium complexes. Cereals, grains, organ meats, muscle meats, and 
dairy products contain selenium, but ranges vary among these sources. Dietary selenium is found 
primarily as selenomethionine in plants, and selenocysteine in animals. Selenium is well absorbed 
primarily in the duodenum. Vitamins A, C, and E, and reduced glutathione (GSH) enhance its 
absorption, while heavy metals and phytates inhibit selenium absorption by chelation and 
precipitation8. 
Selenium is an essential cofactor for enzyme glutathione peroxidase (GPX) and there are several 
forms of this endogenous enzyme. GPX catalyzes H2O2 and hydroperoxide removal from tissues, 
therefore assisting in the actions of an antioxidant system16. The availability of selenium affects 
GPX activity. Deficiency of selenium results in decreased GPX activity, GPX concentrations, and 
GPX mRNA concentrations82-84. GPX found in the cytosol is a selenoprotein with protective 
antioxidant effects on hemoglobin in red blood cells16.  
Selenoprotein P is a glycoprotein functioning as an antioxidant by removing peroxynitrite 
radicals, which are activated by white blood cells and can cause DNA single-strand breaks and 
lipid peroxidation85. Selenium function can be affected in the body by iron and copper 
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deficiencies; iron deficiency decreases hepatic GPX synthesis and reduces tissue selenium 
concentrations, and copper deficiency decreases GPX activities86-88. 
 
B. Trace element status in individuals with obesity and dyslipidemia 
  There are a number of studies reporting trace mineral status in obese individuals and 
those with the metabolic syndrome89-92. In a study by Liang et al. in overweight/obese subjects, 
trace elements, such as iron, zinc, copper, and selenium were significantly increased in the plasma 
compared to normal weight individuals93. In another study, elevated iron stores were correlated 
with abnormal glucose metabolism, a predictor of type 2 diabetes94. Iron has also shown to be a 
pro-oxidant in subjects with dyslipidemia due to its ability to oxidize LDL cholesterol95,96. Iron 
being a catalyst for hydroxyl radical formation, when present in high concentrations, may 
promote oxidative stress in pancreatic β cells97. Thus, iron may play a role in increasing risks for 
developing type 2 diabetes or insulin resistance in the obese population, mainly due to the 
associations with increased oxidative stress, insulin resistance and obesity98. Zinc and selenium 
are typically lower  in obese subjects compared to normal weight individuals, while copper levels 
have been reported to be inconsistent and have been shown to be elevated or lowered in obese 
subjects vs. normal weight individuals9-12.  
 
Table 1: Observational studies on trace element status in obesity, dyslipidemia and related 
CVD risk factors 
 
Trace 
Element 
Sample Population Study Design 
and Methods 
Study Findings Reference 
Iron Overweight male 
adults (n=1,416);  
BMI 26.66 kg/m2; 
20-49 years 
Cross-
sectional; 
NHANES 
(1988-1994) 
Waist-to-hip ratio 
positively correlated with 
serum ferritin 
Gillum et 
al., 200199 
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Iron Overweight male 
adults (n=860); 
BMI 28.29 kg/m2; 
40-74 years 
Cross-
sectional; 
NHANES 
(1988-1994) 
Plasma TG levels positive 
correlated with serum 
ferritin levels in age 
subgroups 40-69 years 
Gillum et 
al., 
2005100 
 
Iron Overweight male 
(n=2,880) and 
female (n=3,069) 
adults with 
metabolic 
syndrome; waist 
circumference ≥102 
cm for men and 
≥88 cm for women; 
≥20 years 
Cross-
sectional; 
NHANES 
(1988-1994) 
Ferritin levels positively 
correlated with metabolic 
syndrome and individual 
components, including 
plasma TG 
Jehn et 
al., 
2004101 
Iron Overweight male 
(n=436) and female 
(n=379) adults; 
BMI 25.0 kg/m2; 
mean age 26 years 
Longitudinal 
cohort 
In women: serum ferritin 
positively correlated with 
waist measurement, BMI, 
and TG.  
In men: positive 
correlation with serum 
ferritin and waist 
measurement, BMI, 
HDL, and TG 
Williams 
et al., 
2002102 
Zinc Obese male (n=11) 
and female (n=12) 
children and 
adolescents; BMI 
30.1 kg/m2; mean 
age 11 years 
Case-control Lower plasma Zn 
concentrations in obese 
individuals 
Marreiro 
et al., 
20049 
Zinc Overweight female 
(n=23) adults who 
were on 
hypocaloric, 
Kawaga healthy 
diet for 6 months; 
BMI 25.5 kg/m2; 
mean age 54 years 
Randomized 
controlled 
↑ Plasma Zn before tx 
↓ body weight, BMI and 
percent body fat 
Ishikawa 
et al., 
2005103 
Zinc Overweight male 
(n=51) and female 
(n=190) adults; 
BMI 31.56 kg/m2; 
mean age 39 years 
Case-control ↓ serum Zn and SOD 
activity in the overweight 
group compared to 
control 
↑ serum Zn and SOD 
activity in female 
overweight group 
compared to male 
overweight group 
Tungtron-
gchitr et 
al., 200310 
Zinc Obese male (n=62) 
and female (n=81) 
children and 
adolescents; BMI 
Case-control ↓ serum Zn in obese 
compared to control and 
inversely correlated with 
skinfold thickness 
Perrone et 
al., 199811 
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>95th percentile; 
mean age 11 years 
Copper Overweight male 
(n=51) and female 
(n=190) adults; 
BMI 31.56 kg/m2; 
mean age 39 years 
Case-control ↑ serum ceruloplasmin 
and Cu in overweight 
subjects compared to 
control 
↑ serum ceruloplasmin 
and Cu in female 
overweight group 
compared to male 
overweight group 
Tungtron-
gchitr et 
al., 200310 
 
Copper Obese male (n=62) 
and female (n=81) 
children and 
adolescents; BMI 
>95th percentile; 
mean age 11 years 
Case-control Serum Cu inversely 
correlated with age 
Perrone et 
al., 199811 
 
Copper Overweight male 
(n=167)  and 
female (n=173) 
adults, BMI 26.8 
kg/m2; mean age 44 
years 
Cross-
sectional 
↓ Cu in obese subjects 
↑ in sedentary subjects 
(obese or normal weight) 
Sanchez 
et al., 
2010104 
Selenium Overweight male 
(n=2,605) and 
female (n=2,847) 
adults; BMI 28.1 
kg/m2; mean age 43 
years 
Cross-
sectional; 
NHANES 
(1988-1994) 
↑ serum Se correlated 
with total cholesterol, 
HDL, LDL, and TG 
 
Bleys et 
al., 
2008105 
 
Selenium Male adults 
(n=364); BMI not 
reported; ages 21-
59 years 
Cross-
sectional 
Se positively correlated 
with serum cholesterol 
after adjustment for age 
and BMI 
Jossa et 
al., 
1991106 
 
Selenium Male (n=264) and 
female (n=309) 
children; BMI 18.9 
kg/m2 (15% 
overweight and 
14.7% obese); 
mean age 10 years 
Case-control ↓ serum Se in children 
with excess weight 
(BMI>P85) compared to 
normal weight children 
↓ Se intake in obese 
children compared to 
normal weight 
Serum Se negatively 
correlated with all 
anthropometric variables 
recorded  
Serum Se negatively 
correlated with BMI 
Ortega et 
al., 201212 
BMI – body mass index; NHANES – National Health and Nutrition Examination Survey; TG – 
triglycerides; Zn – zinc, tx – treatment, HDL – high-density lipoprotein, LDL – low-density lipoprotein,  
SOD – superoxide dismutase, Cu – copper, Se – selenium, CHD – coronary heart disease 
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Excess stored iron and increased risk for CVD was first identified in 1981 in a study assessing 
iron status and sex differences107. Ferritin, an iron storage protein, is found in cells of the liver, 
spleen, heart and kidneys. Serum ferritin concentrations correlate well with iron stored in the 
body. In a study assessing iron status in Mexican-American men aged 20-49 years, the 
researchers measured waist-to-hip ratio, waist-to-thigh ratio, ratio of subscapular to triceps 
skinfold thickness, and central-peripheral skinfold ratio, and revealed positive relationships with 
serum ferritin levels in all age groups of the study sample population99. Another study in adults 20 
years or older reported increased serum ferritin with both increased abdominal adiposity and the 
prevalence of elevated triglycerides in men and postmenopausal women101. A third study in 26 
year old males also found correlations between iron and waist circumference, BMI, and 
triglycerides, while men showed positive correlations between iron and BMI and waist 
circumference, but negative correlations with HDL-cholesterol and triglycerides. Serum ferritin in 
women was also strongly associated with CRP, thus increasing risks of CVD102. Abundant iron 
stores could promote lipid peroxidation and accelerate atherogenesis and CVD108-111. Catalytic 
iron converts ROS into highly reactive radicals, leading to elevated oxidative stress108. 
Serum zinc has been found to be lower in obesity than in healthy weight individuals in several 
studies9,10,44,112. Normal weight individuals have a higher zinc status and lower risks for 
developing diabetes, while lower zinc status was observed for obese subjects113. A study 
examining  plasma levels of biomarkers after weight-loss in obese women showed higher zinc 
concentrations after weight loss and decreased BMI compared to baseline levels103. Similar 
results were seen in a study conducted in adolescents and children114. 
Higher serum ceruloplasmin and copper have been observed in some obese populations than in 
non-obese subjects10,115. These elevated levels could be a result of the body’s demand for copper 
as an antioxidant to reduce LDL oxidation (in obese subjects with dyslipidemia). Yet, since 
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copper can act as a pro-oxidant, high serum copper can cause peroxidation of LDL cholesterol115. 
Serum copper has been found to be inversely related to HDL cholesterol, and the zinc/copper 
ratio showed a positive correlation with HDL cholesterol as well116. However, some studies show 
low copper levels in obese individuals versus non-obese individuals11. 
Selenium levels in normal weight, overweight, and obese subjects showed a positive association 
with total cholesterol, HDL cholesterol, LDL cholesterol, and triglycerides105. Other studies have 
also reported similar correlations106,117-119. Since selenium is a cofactor for the GPX enzyme, it 
has been studied in association with CVD. While high levels of selenium in plasma haven’t been 
shown to be beneficial, low amounts have been correlated with CVD risk factors119-122. Low 
amounts of plasma selenium have been associated with vascular dysfunction, and this could also 
be linked with dyslipidemia123.  
 
C. Endogenous antioxidants 
Cells protect themselves against oxidative stress by endogenous, enzymatic antioxidants, 
including SOD, CAT, and GPX, in a highly organized endogenous defense system124. These 
enzymes are important in reducing oxidative stress; SOD converts a superoxide radical into a 
hydroxyl radical and then to H2O2, followed by the action of CAT and GPX converting the H2O2 
molecule into  free oxygen and water molecules125. They are also important regulators of redox-
sensitive signaling pathways14.  
 
Figure 1: The antioxidant defense system including SOD, CAT, and GPX 
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Li et al., 2000126 
 
SOD converts superoxide radical into a hydroxyl radical and then to H2O2, as evidenced by 
increased levels of
 
H2O2 with increased cellular SOD activity127. There are three different 
isoforms of SOD found in mammals, all of which catalyze the same reaction: CuZnSOD (SOD1), 
MnSOD (SOD2), and ecSOD (SOD3). SOD1 is found in the cell cytoplasm, mitochondrial inter 
membrane space, nucleus, lysosome, and peroxisome. SOD2 is found in mitochondrial matrix, 
while SOD3 is located in extracellular matrix, cell membrane, and extracellular fluids. SOD 
location within the cell is important for redox signaling. SOD conversion of O2- to H2O2 includes 
reduction and reoxidation of a transition metal at the enzyme’s active site, such as copper or 
manganese. Thus, SOD requires the presence of a catalytic metal to carry out its role in the 
antioxidant defense system127. 
Catalase (CAT), found in the cytosol and cell peroxisomes, contains four heme iron groups which 
are helpful to recognize and react to H2O2 as its substrate128,129. CAT  functions at a very low 
affinity. Thus, catalase may mainly function when H2O2 levels are above the physiological level, 
such as during an oxidative burst in response to stress. Peroxisomes produce H2O2 under 
physiologic conditions, but not O2-. Thus, catalase is found in this organelle to decompose H2O2 
and prevent an accumulation of this damaging compound. If a peroxisome is badly damaged and 
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catalase is down-regulated, H2O2 will be released into the cytoplasm and contribute to significant 
oxidative stress128.  
GPX activity is said to represent the initial defense response to optimize H2O2 concentration 
under both normal and stressful conditions38. A high selenium intake is thought to increase GPX 
activity, thus decreasing the amount of H2O2 in the cell130. Glutathione, the co-factor for GPX is 
synthesized in the cytosol and is found in large concentrations in the cytosol, nucleus, and 
mitochondria124,131. Glutathione is protective against oxidative stress with its many roles, 
including as a cofactor of detoxifying enzymes that prevent oxidative stress (GPX, glutathione 
transferase, etc.), participation in singlet oxygen scavenging abilities, H2O2 and lipid peroxide 
detoxification, and its ability to regenerate vitamins C and E back to their reduced forms124.  
Glutathione may be found in two forms: oxidized glutathione disulphide (GSSG) and reduced 
glutathione (GSH). GPX is the enzyme that calalyzes the compound H2O2 to H2O and free 
oxygen, while GSH is oxidized to GSSG simultaneously.  GSH’s role in the nucleus is to 
maintain the redox balance for necessary DNA repair and expression. An accurate measurement 
of oxidative stress in an organism is to determine the GSH/GSSG ratio. Excessive GSSG 
concentration may impair GPX activity, as GSH is GPX’s substrate and is oxidized to GSSG 
when GPX acts to catalyze H2O2132.  
  
 
Table 2: Plasma antioxidant status in individuals with obesity and/or dyslipidemia 
     
Sample Population Study Design 
and Methods 
Significant 
Findings about 
Plasma 
Antioxidants 
Other 
Significant 
Study Findings 
Reference 
Obese male (n=100) 
and female (n=160) 
Observational BMI positively 
correlated with 
Severe obesity 
positively 
Olusi et 
al., 200241 
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adults; BMI 19->50 
kg/m2; mean age 41 
years 
plasma MDA 
BMI negatively 
correlated with 
SOD and GPX 
activity 
correlated with 
lipid 
peroxidation 
Obese female adults 
(n=36); mean BMI 
38.5 kg/m2; mean 
age 35.4 years 
Randomized 
control 
Before weight 
loss, obese 
women had 
significantly ↓ 
GPX compared 
to healthy 
weight controls 
After weight 
loss, ↑ GPX 
compared to 
before weight 
loss  
 
After weight 
loss, ↓ GPX 
compared to 
control 
Bougou-
lia et al., 
2006133 
Obese male (n=23) 
and female (n=31) 
children; BMI 25.4 
kg/m2; mean age 9 
years 
Case-control ↑ SOD in obese 
children 
compared to 
control 
↑ cholesterol in 
obese children 
compared to 
control 
Sfar et al., 
2013134 
Obese (n=27) and 
non-obese (n=57) 
female adults with 
and without PCOS; 
BMI of obese group 
33.6 kg/m2; mean 
age 31 years 
Case-control  ↑ CAT activity 
in obese women 
with and without 
PCOS compared 
to non-obese 
control  
↑ serum GPX 
activity in obese 
group without 
PCOS compared 
to non-obese 
group without 
PCOS 
Bausen-
wein et 
al., 
2010135 
Obese male (n=30) 
and female (n=103) 
adults; BMI 31.4 
kg/m2; mean age 43 
years 
Case-control  ↑ serum GPX-3 
in obese group 
compared to 
control 
↑ TAG and ↓ 
HDL in obese 
compared to 
control  
Baez-
Duarte et 
al., 
2012136 
MDA – malondialdehyde (reactive species); BMI – body mass index; GPX – glutathione peroxidase; SOD 
– superoxide dismutase; CAT – catalase; GPX-3 – Nonselenocysteine-containing phospholipid 
hydroperoxide glutathione peroxidase; PCOS – polycystic ovary syndrome; WHR – waist-to-hip ratio; 
TAG – triacylglycerides 
 
Antioxidant enzymes are found in the vascular wall in order to reduce ROS and defend cells from 
oxidative damage and prevent development of diseases like atherosclerosis129. There is no current 
evidence expressing a correlation between dyslipidemia presence and plasma antioxidant status, 
but the effect of obesity on antioxidant status varies. In a study examining levels of  GPX and 
CuZn-SOD enzymes in humans, the authors reported that  BMI negatively correlated with levels 
of these endogenous antioxidant enzymes, while BMI positively correlated with plasma MDA41. 
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Similar results of decreased plasma antioxidants were found in a number of other studies in obese 
adults137, obese children138, obese male children139, and obese female children140. Yet, Olusi et al. 
proposed that initiation of obesity is associated with a stimulation of antioxidant enzyme activity. 
However, once obesity becomes persistent, the antioxidant enzyme activity and reserves become 
depleted, as indicated by the findings in the study41. Over time, low activity of cytoprotective 
enzymes like GPX and catalase may lead to progressive tissue damage, atherosclerosis, cancer, 
and other chronic conditions41. Many other findings shown in Table 2 indicate that activity of 
SOD, catalase, and GPX may be elevated in the presence of obesity134-136, and that weight loss 
may potentially improve these values compared with baseline values133. 
 
D. Polyphenols 
Polyphenols are commonly consumed plant-derived compounds in the diet and are present mostly 
in fruits, vegetables, fruit juices, wine, black tea, green tea, coffee, as well as in cereals, 
chocolates, and dry legumes. These compounds contribute to the food’s color, odor, flavor, and 
oxidative stability17. Since the mid-1990s, these compounds have been recognized for their health 
benefits and disease prevention characteristics19,141-143. Strong supporting evidence shows that 
polyphenols may confer protection against  CVD, cancer, osteoporosis, neurodegenerative 
diseases, and diabetes mellitus18-20. Polyphenols  have been shown to reduce CVD risk factors, 
such as lowering total TGs, total cholesterol, LDL-cholesterol, BMI, and waist 
circumference22,144.  The polyphenol content of selected foods is shown below in Table 3: 
Table 3: Commonly consumed polyphenol-containing foods in the US 
 
Food source 
 
Polyphenol content per 
serving 
(mg/serving) 
Type of polyphenol  Calories per 
100 g 
(kcal) 
Strawberry 27.01 Anthocyanins 32 
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 4.6 
1.65 
0.26 
Flavan-3-ols 
Flavonols 
Flavanones 
Blackberry 100.61 
42.4 
4.52 
Anthocyanins 
Flavan-3-ols 
Flavonols 
43 
Blueberry 163.3 
6.69 
10.63 
0.2 
Anthocyanins 
Flavan-3-ols 
Flavonols 
Flavones 
57 
Gala Apple 1.22 
8.21 
3.8 
Anthocyanins 
Flavan-3-ols 
Flavonols 
52 
Soybeans 37.41 Flavan-3-ols 70 
Red wine 19.27 
11.08 
2.4 
1.57 
Anthocyanins 
Flavan-3-ols 
Flavones 
Flavonols 
85 
Candies, milk 
chocolate 
10.88 Flavan-3-ols 535 
Potato 1.5 Flavonols 97 
Manach, et al., 2004; United States Department of Agriculture, 2009145-147 
 
Many factors affect polyphenol content in fruits , including exposure to light, ripeness of the fruit, 
soil type in which the fruit was grown, fruit yield per tree, processing, and storage148. Food 
processing can significantly alter polyphenol content, especially those involving vacuum and 
convection methods of drying149. Wojdylo et al. reported that freeze-drying versus vacuum 
microwave drying methods did not significantly alter polyphenol compounds in strawberries149. 
Polyphenols in cocoa and berries have been shown to lower blood pressure, increase HDL-
cholesterol150,151, decrease inflammatory markers, and overall decrease risks for cardiovascular 
mortality151,152. Polyphenols such as those found in green tea may decrease lipid digestion and 
absorption by decreasing digestive enzyme activity and lipid emulsification153. Tea catechins 
neutralize  reactive oxygen and nitrogen radicals, as well as act upon metal ion chelators that are 
active in the redox system154. Green tea, resveratrol, and curcumin have been shown to reduce 
adipocyte fat accumulation by activation, inhibition, and down-regulation of lipogenic enzymes 
and genes155-158.  Furthermore, phenolic compounds in various foods have been shown to affect 
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trace mineral and endogenous antioxidant levels, as well as LDL cholesterol oxidation, thus 
modulating disease risks in humans8,57,159-165. 
In cell culture studies, polyphenols have been shown to alter trace minerals, such as iron and zinc 
absorption in the human enterocyte166-169. Reported studies include polyphenol-rich supplements 
such as green tea, green tea extract, or grape seed extract. Ma et al. reported a significant decrease 
in iron absorption when enterocytes were treated with polyphenols and iron, when compared to 
the iron only treated control group166. Iron transfer across the basolateral membrane was 
significantly lower in the enterocytes treated with iron and polyphenols versus iron only, leading 
to the observation that polyphenols may form complexes with iron in the cell and prevent iron 
from leaving the basolateral membrane. However, zinc uptake has been shown to be increased or 
unchanged in the presence of EGCG and green tea compared to the control group170,171. Specific 
polyphenols may bind with zinc and form a complex which improves mineral absorption, but the 
transport and cellular bioavailability of the complex thereafter remains unknown. Thus, 
polyphenols can significantly alter trace element status in vivo, especially those that are known to 
modulate oxidative stress and antioxidant status. 
 
Table 4: Effects of polyphenols on trace element uptake in cell models (human Caco-2) 
Duration Polyphenol-Rich Source Significant Study Findings Reference 
3 hour 
incubation 
Phytate (66 mg/L);  
EGCG (46 mg/L); GT 
(46 mg/L); or GSE (46 
mg/L) 
↓ Fe uptake with EGCG, GT, and 
GSE tx 
↓ apical Zn uptake with GSE tx 
↓ Zn uptake with phytate tx 
Kim et al., 
2000170 
7 hour 
incubation 
EGCG (0.46, 4.6, or 46 
mg/L); GT (0.46, 4.6, or 
46 mg/L); or GSE (0.46, 
4.6, or 46 mg/L) 
↓ Fe uptake by EGCG, GSE and GT 
compared to control 
 
Ma et al., 
2012172 
7 hour 
incubation 
EGCG (46 mg/L) or 
GSE (46 mg/L) 
↓ Fe uptake by EGCG and GSE tx Ma et al., 
2010167 
3 hour 
total 
2 mL RW, RGJ, or GT; 
or 200 µmol/L tannic 
↑ Zn uptake with RW, RGJ, and GT 
tx compared to control 
Sreeniva-
sulu et al., 
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incubation acid, quercitin, catechin, 
gallic acid, or caffeic 
acid 
↓ Zn uptake with RW fraction 
excluding polyphenols  
↑ Zn uptake with tannic acid and 
quercitin tx compared to control 
2010171 
24 hour 
incubation 
0.73 mL apple, pear, 
white grape, RGJ, prune, 
grapefruit, or orange 
juice 
↓ Caco-2 cell ferritin formation (from 
iron) with RGJ and prune juice tx 
compared to control 
Boato et 
al., 
2002173 
Fe – iron, Zn – zinc, treatment – tx, DMEM – Dulbecco’s Modified Essential Medium, EGCG – 
epigallocatechin-3-gallate, GT – green tea, GSE – grape seed extract, RW – red wine, RGJ – red grape 
juice 
 
Altered levels of trace elements have been observed in healthy animal models following dietary 
supplementation of polyphenols174-176. Polyphenols have also been shown to alter endogenous 
antioxidant activity in animals models of  diet-induced obesity, which may alter absorption and 
activity of the trace minerals that are structural constituents of endogenous antioxidant 
systems177,178.  
Table 5: Effects of polyphenols on general antioxidant status in diet-induced animal models 
of obesity 
Animal Model Duratio
n 
Polyphenol-
Rich Source 
Significant Study Findings Reference 
Male Sprague 
Dawley rats 
(n=40), fed 
normal or HF 
diet with or 
without red 
grape skins 
Four 
weeks 
Red grape 
skins, 20 
mg/kg/day 
↓ CAT activity in HF diet compared 
to normal diet control 
↑ CAT and SOD in HF and normal 
diet with red grape skin tx  
↑ GSH/GSSG ratio in normal diet 
and red grape skin tx + normal diet 
Lee et al., 
2009174 
Sprague Dawley 
female rats 
(n=36), fed 
normal, HF, or 
HF diet + GTP 
Eight 
months 
(four 
months 
with 
GTP) 
GTP, 0.5% 
(wt/vol) of 
distilled 
water 
↑ liver GPX activity in HF + GTP 
compared to HF diet control  
Shen et al., 
2012175 
Obese Zucker 
fatty rats (n=24), 
fed normal diet 
or diet + RWP 
Eight 
weeks 
RWP, 20 
mg/kg/day 
↓ O2− from aorta, carotid arteries, 
and SMA with RWP tx compared to 
control 
Agouni et 
al., 2009176 
HF – high-fat, CAT – catalase, SOD – superoxide dismutase, GSH – reduced glutathione, GSSG – oxidized 
glutathione, GTP – green tea polyphenols, RWP – red wine polyphenols, SMA - small mesenteric artery 
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i. Strawberries: bioactive compounds  
Strawberries, among many other berries, are rich in vitamins and polyphenols beneficial in 
disease prevention and overall health promotion.  Phytochemicals of particular interest found in 
strawberries include glycosides anthocyanins and 2,5-dimethyl-4-hydroxy-3-[2H] furanone 
(DMHF), catechins, ellagic acid and hydroxycinnamic acid derivatives, and flavanols, such as 
quercetin and kaempferol149,179-181. Strawberries contain both free and bound phenolics. Bound 
polyphenols may remain undigested in the stomach and intestine and then be acted upon by 
bacteria in the colon. Strawberries contain 92.3% of their polyphenols in the free form, allowing 
the small intestine to absorb them and then these may be utilized in the body182. Polyphenol 
content, ferric reducing ability of plasma (FRAP), and Trolox equivalent antioxidant capacity 
(TEAC) in strawberries are significantly decreased during processing methods, including 
mashing, pressing juice, filtering juice, pasteurizing juice, and pureeing. However, anthocyanin 
composition is significantly increased during processing methods like mashing and pureeing183.  
Table 6: Nutritive value and composition of fresh strawberries 
Nutrient Unit Value per 100 g 
Water g 90.95 
Energy Kcal 32 
Total lipid g 0.3 
Protein g 0.67 
Fiber, total dietary g 2.0 
Total carbohydrate g 7.68 
Sugars g 4.89 
Iron mg 0.41 
Zinc mg 0.14 
Vitamin A IU 12 
Vitamin C mg 58.8 
Vitamin E mg 0.29 
Agricultural Research Service USDoA, 2014 
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Strawberries are high in vitamin C and polyphenols, as well as fiber and thus have been known to 
reduce serum cholesterol levels and CVD risks in some studies180,184,185. Strawberry consumption 
has been shown to decrease serum glucose, total cholesterol and LDL cholesterol in obese 
adults186,187. Studies involving anthocyanin and ellagitannin consumption have shown that these 
phytochemicals may prevent incidence of cancer, CVD, and age-related decreased 
neurodegenerative function180,188,189. These preventative effects are thought to be associated with  
phenolic acids, mainly due to their antioxidant properties and ability to neutralize ROS  in 
prevention of chronic diseases181.  
Furthermore, consumption of strawberries has been shown to improve plasma antioxidant enzyme 
activity and reduce oxidative stress in healthy human subjects181,190. Experimental studies have 
also shown compounds in strawberries to possess ROS-scavenging activity182,191-193. Compounds 
in strawberry juice have shown to scavenge free radicals such as, O2-, H2O2, and ●OH. Lin et al.  
found that among different berries, strawberries and blackberries have the highest ROS 
scavenging capacity when exposed to the individual reactive compounds, thus providing evidence 
that strawberries contain bioactive antioxidants192. 
 
E. Effects of polyphenols on trace minerals/general antioxidants in human subjects 
with obesity and/or dyslipidemia 
While polyphenols have been found to be beneficial in healthy human populations, they have also 
been shown to reduce risks of chronic diseases in populations with obesity and/or dyslipidemia. 
Mechanisms by which polyphenols may prevent weight gain include their ability to increase 
lipolysis, decrease lipogenesis, stimulate β-oxidation, inhibit adipocyte growth and 
differentiation, and debilitate inflammatory response and oxidative stress194. Another important 
property that polyphenols, especially flavonoids and tannins, possess is the tendency for phenolic 
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hydroxyl groups to chelate metal ions, further contributing to their antioxidant activity164. The 
capacity to bind metals may be relevant to the phenolic antioxidant activity, considering free 
transition metal ions are pro-oxidants which produce free radicals in the presence of H2O2.  Due 
to the presence of phenolic hydroxyl groups, electron delocalization principles allow phenolic 
groups to be readily ionized and thus act as weak acids which can influence chemical reactivity of 
phenolics159.  
Many studies have shown improved levels of selected trace elements195,196, increased total 
antioxidant capacity21,190,195,197,198, and decreased LDL cholesterol oxidation190,197,199 in study 
participants supplemented with a polyphenol-rich source (Table 7). 
 
Table 7: Effects of polyphenols on trace elements and general antioxidant 
status/endogenous antioxidants in overweight or obese participants with/without 
dyslipidemia 
Sample 
Population 
Study Design 
and Methods 
Duration Polyphenol-
Rich Source 
Significant Study 
Findings 
Reference 
Obese male 
(n=23) and 
female (n=23) 
adults; BMI 
32.76 kg/m2; 
mean age 50 
years 
Randomized, 
double-blind, 
placebo-
controlled  
Three 
months 
379 mg GTE ↓ BMI, waist 
circumference, 
serum TC, LDL-
cholesterol, and 
TG levels 
compared to 
control 
↑ TAC after tx 
compared to 
control 
↓ serum Fe and 
Zn after tx 
compared to 
baseline 
Sulibur-
ska et al., 
2012 21 
Male (n=5) and 
female (n=20) 
adults with 
mild 
dyslipidemia; 
Randomized 
control  
12 weeks Three tablets 
of 280 mg 
mulberry leaf 
powder, three 
times daily 
↓ TC/HDL ratio 
and serum TG 
and LDL levels 
compared to 
control 
Aramwit 
et al., 
2013200 
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BMI 23.18 
kg/m2, mean 
age 36 years 
Overweight 
female adults 
(n=8); BMI 
26.1 kg/m2; 
mean age 67 
years 
Clinical  Four 
hours 
240 g fresh 
strawberries 
↑ serum 
antioxidant 
capacity during 
initial four hours 
after consumption 
compared to 
control 
Cao et al., 
1998190 
Overweight 
male adults 
(n=21); BMI 
26.9 kg/m2; 
mean age 38 
years 
Clinical  14 days 7 mL/kg 
cranberry 
juice 
↓ plasma oxLDL 
levels compared 
to baseline 
 
↑ plasma 
antioxidant 
capacity 
compared to 
baseline 
Ruel et al., 
2005197 
Obese male 
(n=13) and 
female (n=15) 
adults with 
HTN; BMI 
32.5 kg/m2; 
mean age 49 
years 
Randomized 
double-blind, 
placebo-
controlled 
Three 
months 
379 mg GTE ↑ TAC compared 
to control 
Bogdan-
ski et al., 
2012 198 
Obese male 
(n=22) and 
female (n=25) 
adults; BMI 
30.59 kg/m2; 
mean age 57 
years 
Randomized, 
parallel and 
double-blind 
case-control 
Four 
weeks 
1.4 g cocoa 
extract (645.3 
mg of 
polyphenols) 
↓ plasma oxLDL 
and MPO in tx 
group compared 
to control 
Ibero-
Baraibar 
et al., 
2013199 
Obese male 
(n=8) and 
female (n=27) 
adults with 
metabolic 
syndrome; 
BMI 36.33 
kg/m2; mean 
age 42 years 
Single-
blinded 
randomized 
controlled 
Eight 
weeks 
4 cups/day 
green tea, or 
2 capsules 
(870 mg 
catechins) 
GTE 
↑ whole blood 
GSH and plasma 
antioxidant 
capacity in GTE 
tx group and 
green tea tx group 
compared to 
control 
↓ plasma Fe in 
GTE tx group 
compared to 
baseline 
↑ plasma Cu in 
green tea tx group 
compared to GTE 
tx group after tx 
Basu et 
al., 
2013195 
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Overweight 
male (n=10) 
and female 
(n=14) adults 
with 
hyperlipidemia; 
BMI 29.2 
kg/m2; mean 
age 51 years  
Randomized, 
single-blind, 
placebo-
controlled, 
crossover  
12 weeks 
(6-week 
crossover 
point) 
10 g FDS 
beverage 
(338 mg total 
phenolic 
compounds) 
with high-fat 
meal 
↓ plasma oxLDL 
after FDS 
beverage 
supplementation 
compared to 
placebo 
Burton-
Freeman 
et al., 
2010201 
GTE – green tea extract, BMI – body mass index, TC – total cholesterol, LDL – low-density lipoprotein, 
TG – triglycerides, TAC – total antioxidant capacity, Zn – zinc, Fe – iron, tx – treatment, GPX – 
glutathione peroxidase, HDL- high-density lipoprotein, HTN – hypertension, oxLDL – oxidized low-
density lipoprotein, MPO – myeloperoxidase, GSH – glutathione, Cu – copper, FDS – freeze-dried 
strawberry 
 
Adults with obesity and dyslipidemia have increased oxidative stress and an increased risk for 
CVD. Trace elements have been shown to be altered in subjects with obesity and dyslipidemia, as 
iron is typically elevated and has a pro-oxidant effect, while zinc and selenium can act as 
antioxidants and are typically decreased in this population. Dietary and antioxidant defense 
enzymes are typically lower in obese and dyslipidemic populations compared to the healthy 
population, Plasma trace element and antioxidant levels are significant indicators of oxidative 
stress, which may contribute to the pathophysiology of chronic diseases, especially CVD. 
Strawberries and other polyphenol-rich foods have been shown to improve trace element and 
antioxidant status in subjects with obesity.  
While research provides some evidence on the role of polyphenols in improving antioxidant 
status and altering trace element levels, there is a lack of clinical data on the role of strawberries 
in modulating these biomarkers, especially in subjects with obesity and dyslipidemia. With the 
dramatic increase in the prevalence of obesity, dyslipidemia, and related chronic health conditions 
like CVD associated with elevated oxidative stress, there is an urgent need for research in this 
area. Thus, we intend to address this research gap and examine the effects of strawberries on 
plasma trace elements, especially iron, copper, zinc, and selenium, and antioxidants such as 
catalase and GSH in subjects with obesity and dyslipidemia. We hypothesize that the 
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consumption of freeze-dried strawberries will affect the levels of trace elements, especially lower 
plasma iron, in obese individuals with above optimal serum lipids when compared to the control 
group. We also hypothesize that the consumption of freeze-dried strawberries will affect the 
levels of endogenous antioxidants, especially plasma catalase and GSH in obese individuals with 
above optimal serum lipids when compared to the control group in a 12-week intervention trial. 
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CHAPTER III 
 
 
METHODOLOGY 
 
3.1 Participants and study design 
Male and female adults (≥21 years) with abdominal adiposity (waist circumference in men >40 
inches, women >35 inches) and dyslipidemia (two of four criteria: fasting total cholesterol 
>200mg/dL, triglycerides >150mg/dL, LDL-cholesterol >100 mg/dL, or HDL-cholesterol 
(men<40mg/dL, women <50 mg/dL), as defined by National Cholesterol Education Program 
(NCEP), Adult Treatment Panel (ATP) III were included in the study. Subjects with normal liver, 
kidney, and thyroid function tests were included in the study. Subjects on stable 
multivitamin/mineral supplements or prescription medications (except hypolipidemic, 
hypoglycemic, and steroid agents) were included in the study. Subjects with any form of pre-
existing disease, e.g. cancer, heart disease, diabetes (fasting blood glucose ≥126mg/dL), liver, or 
renal disorders, anemia, pregnancy and lactation, taking mega doses of antioxidants/fish oil 
supplements (> 1g/day), taking hypolipidemic, hypoglycemic, and steroid medications, abnormal 
hemoglobin (normal range: 12.0-18.0 g/dL), white blood cell (normal range: 4.0-11.0 thousands 
per cubic milliliter (K/mm3)), or platelets (140-440 K/mm3), hypo/hyperthyroidism (normal range 
for thyroid stimulating hormone: 0.35- 4.940 µIU/mL), abnormal liver enzymes (normal range for 
aspartate aminotransferase (AST): 7-40 units/L; alanine aminotransferase(ALT): 10-45 units/L), 
abnormal kidney function (normal creatinine: females- 0.7-1.2 mg/dL; males- 0.8-1.2 mg/dL; 
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normal blood urea nitrogen (BUN): 1-59 years- 7-18 mg/dL; > 59 years- 8-21 mg/dL), smoking, 
and drinking alcohol (>1oz/day) were excluded from the study. Both males and females, as well 
as individuals from any ethnic group, who qualify, were included in the study. People who have 
ever been allergic to strawberries were excluded from the study. The study was approved by the 
ethics committees at the Oklahoma University Health Sciences Center (OUHSC) and at 
Oklahoma State University (OSU), and all participants provided written informed consent prior to 
any study procedures. 
Subjects were recruited at the General Clinical Research Center (GCRC) at Oklahoma University 
(OU) and at the Department of Nutritional Sciences (NSCI) at OSU via flyers and campus e-mail 
advertisements (30 subjects/site). Following an initial telephone screen, subjects were scheduled 
for a screening visit and qualification was confirmed based on the two qualifying measurements 
of abdominal adiposity and dyslipidemia, as mentioned earlier. Upon qualification, subjects were 
then randomized using a block randomization design to account for the effects of age and gender 
on the variables of interests. Participants were recruited into quartets matched for age (± 5 years) 
and gender. The age and gender for a quartet was determined by the first participant assigned to 
that quartet. The next consecutive participant that met the matching criteria of that quartet was 
assigned as the second participant of that quartet, and so on. Each quartet had one participant in 
each of the four intervention groups: low fiber/calorie control, low freeze-dried strawberries 
(FDS) beverage, high fiber/calorie control, or high FDS beverage. While quartets had been filled 
consecutively within the matching parameters, the intervention to which the first, second, third, 
and fourth participants in the quartet was assigned was pre-determined by random permutation. 
All participants consumed two cups of FDS or control beverage. Each cup contained 12.5 g FDS 
blended in 1 cup water with added Splenda (optional) in the low dose group, or 25 g FDS blended 
in 1 cup water with added Splenda (optional) in the high dose group. The matched control 
beverage contained 2 g fiber (vegetable fibers and natural gums, containing both insoluble and 
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soluble fiber (1:2) per serving (Fiberstir)) and 2 tsp sugar blended in 1 cup water in the low 
fiber/calorie control group, or 4 g fiber (vegetable fibers and natural gums, containing both 
insoluble and soluble fiber (1:2) per serving (Fiberstir)) and 4 tsp sugar blended in 1 cup water in 
the high fiber/calorie control group. The control beverage also had artificial strawberry flavor and 
food color added to the drinks. The low dose FDS and matched control beverage contained equal 
amounts of fiber (4 g) and calories (75 kcal) per day, while the high dose FDS and matched 
control contained 8 g fiber and 150 kcal per day for 12 weeks (Table 8). 
All subjects came for three days/week of mandatory visits to the research facilities to ensure 
compliance and the remaining quantity of the beverages had been provided in containers for later 
consumption. All subjects were asked to follow usual diet and lifestyle, and refrain from other 
sources of berries and related products while on the study. Subjects also maintained 3-day food 
records at screen, 6 and 12 weeks of the study. Height, weight, blood pressure, and waist 
circumference was measured by trained personnel at GCRC and at NSCI at screen and at 12 
weeks of the study. Blood draws were performed by trained nurses at GCRC and by trained 
phlebotomists at Stillwater Medical Center at OSU. 
Fasting blood samples were immediately sent to OU Medical Center laboratory (Oklahoma City, 
Oklahoma) or the Stillwater Medical Center laboratory (Stillwater, Oklahoma) for comprehensive 
metabolic panel (CMP) including glucose, insulin, glycated hemoglobin, lipid panel, electrolytes, 
liver, kidney, thyroid tests, and complete blood count. Remaining plasma and serum samples 
were stored at -80ºC for subsequent analyses.  
3.2 Plasma trace elements 
Plasma levels of iron, zinc, copper, and selenium were measured using inductively coupled 
plasma mass spectroscopy (Elan 9000; Perkin Elmer, Norwalk, Connecticut) based on previously 
published procedures202. Plasma samples were diluted 1:50 in 0.05% Triton X-100 (Sigma-
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Aldrich, St. Louis, Missouri) and analyzed by inductively coupled plasma mass spectroscopy 
(ICP-MS, Elan 9000, Perkin Elmer, Norwalk, Connecticut) with gallium as internal standard. 
Plasma samples were diluted 1:20 in 0.1% nitric acid (GFS Chemicals, Powell, Ohio) and 
analyzed by ICP-MS using gallium as internal standard. The OSU Nutritional Sciences laboratory 
participates in the CDC Laboratory and Multielement Proficiency (LAMP) program. Tri-level 
blood lead control samples and plasma control samples were utilized (Utak Laboratories, Inc., 
Valencia, California) and were within expected ranges. A standard cocktail solution containing 
iron, zinc, copper, and selenium at a concentration of 100 µg/L was prepared (from commercial 
standard 1-g/L solution) and stored in pre-cleaned polyethylene volumetric flasks. A simulated 
blank solution was used to correct for interferences from polyatomic ions [0.14 mol/L nitric acid, 
internal standard (100 µg/L gallium), sodium chloride, sodium nitrate, cysteine, and calcium 
nitrate.] Quantitative analyses were performed using the scanning mode data acquisition. For each 
analyte (iron, zinc, copper, and selenium), peak area (signal) was divided (normalized) by the 
signal of the internal standard. For each element, the average normalized signal of the blank 
solution was subtracted from the average normalized signal of the diluted plasma solution. The 
inter-assay CV was within 5% for each element. 
3.3 Catalase and reduced glutathione 
Serum catalase enzyme activity was measured using Cayman Chemical Company (Ann Arbor, 
Michigan) spectrophotometric Catalase Assay Kit based on the manufacturer’s protocol. Samples 
were pipetted to wells, where 100 µL diluted Assay Buffer, 30 µL methanol, and 20 µL of sample 
were added in duplicates. The reaction was initiated by adding 20 µL of diluted hydrogen 
peroxide to all wells and were incubated on a plate shaker for 20 minutes. Next, 30 µL of diluted 
potassium hydroxide were added to each well to terminate the reaction and the addition of 30 µL 
of catalase purpald (chromogen) followed. Catalase purpald forms bicyclic heterocycles with 
aldehydes, which change from colorless to a purple color upon oxidation. The plate was 
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incubated on the plate shaker for ten minutes, followed by the addition of 10 µL of catalase 
potassium periodate to each well. The wells were incubated on a plate shaker a final time for five 
minutes at room temperature and then immediately analyzed by the microplate reader (Bio-Tek 
Synergy HT Multi-Detection, Winooski, Vermont) at 540 nm. 
Reduced glutathione content in heparinized whole blood sample was measured using the method 
described by Beutler et al203. Briefly, 100 mL of hemolyzed blood sample and 200 mL of 2.5 Mm 
5,5′-dithiobis-2-nitrobenzoic acid (Sigma, St. Louis, Missouri) were mixed in tubes containing 
1.9 mL Tris-HCL buffer, Ph 8.0. The absorbance of the yellow thiolate anion was measured at 
412 nm. GSH (Sigma, St. Louis, Missouri, USA) was used as a standard. Calibration curve was 
used to calculate concentration and was expressed as µg/g hemoglobin. The average inter-assay 
CV was 5.2%. 
3.4 Statistical analyses 
Descriptive statistics were calculated for all parameters, and graphs were drawn to look for 
outliers. The primary objective was to identify differences in means of antioxidant and trace 
element parameters at screening (week 0) and end of study (week 12) between low FDS beverage 
and control, and high FDS and control treatment. Within-group differences were analyzed using 
paired t test. Means at screen and 12 weeks were compared using the multivariate analysis of 
variance (MANOVA). All data were expressed as means ± standard deviation for the variables of 
interests, with significance level set at 0.05. SPSS for Windows (version 15.0, 2006; SPSS Inc, 
Chicago, Illinois) was used for the statistical calculations.
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CHAPTER IV 
 
 
FINDINGS 
 
Baseline characteristics 
Among the 85 participants screened for the study, 66 met the inclusion and exclusion criteria, and 
were enrolled in the study. Among the 66 enrolled, six participants dropped out of the study due 
to their time constraints and inability to make the mandatory three visits per week to the study 
centers. Thus, 60 participants completed the 12-week study in strawberry and control arms. 
Among these participants, compliance was 100% for the strawberry groups and 97% for the 
control groups, as assessed by mandatory weekly visits and any unconsumed beverages. No 
adverse events were reported in the study. At baseline, no significant differences in clinical and 
demographic characteristics were noted in the low dose FDS (25g/day) vs. low dose control 
group and in the high dose FDS (50g/day) vs. HDC (Table 9).  
 
Trace elements 
i. Iron and copper 
As shown in Table 10, at baseline 54Fe was not significantly different between high dose FDS and 
low dose FDS or between high dose FDS and HDC. However, at baseline, 54Fe was significantly 
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lower in the low dose FDS versus LDC (p<0.05). At baseline, 57Fe was not significantly different 
among any groups. There were no significant differences the two iron isotopes measured at 12 
weeks. There were no significant differences in copper at baseline or at 12 weeks among any 
groups. Within-group comparisons revealed no significant differences in plasma iron and copper.  
ii. Zinc and selenium 
No significant differences in zinc or selenium were noted at baseline or at 12 weeks between high 
dose FDS and low dose FDS as well as their respective matched controls. Within-group 
comparisons revealed no significant differences in plasma zinc and selenium (Table 10).  
Catalase 
At baseline, catalase activity was not significantly different between high dose FDS and HDC or 
between low dose FDS and LDC. Yet, at baseline, catalase activity was significantly higher in the 
high dose FDS versus low dose FDS (Table 11.) However, no significant differences were noted 
at 12 weeks among any of the groups. In the high dose FDS group, within-group comparison 
revealed catalase activity to be significantly lower at 12 weeks compared to baseline (Table 11). 
Reduced glutathione (GSH) 
As shown in Figure 3, GSH was not significantly different between high dose FDS and HDC, but 
was significantly higher in the high dose FDS versus low dose FDS and was significantly lower 
in the low dose FDS versus LDC at baseline. At 12 weeks, GSH was significantly higher in high 
dose FDS versus low dose FDS, as well as when compared to its respective control group. 
Within-group comparisons revealed that GSH was significantly higher at 12 weeks compared to 
baseline, in both low dose FDS and high dose FDS groups (Table 12).   
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Table 8: Composition of strawberry and control beverages administered in the 12-week 
study* 
Composition Low dose FDS Low dose control High dose FDS High dose control 
FDS (g)1 25 - 50 - 
Fiber (g)2 4.0 4.0 8.0 8.0 
Calories (kcal) 75 80 150 144 
Protein (g) 1.8 - 3.5 - 
Fat (g) 0.3 - 0.5 - 
Carbohydrates 
(g) 
16 20 32 36 
Ash (g) 1.5 - 3.2 - 
Vitamin C 
(mg) 
55 - 109 - 
Total phenolics 
(mg gallic acid 
equivalents) 
1001 - 2005 - 
Total 
anthocyanins 
(mg cyaniding-
3-glucoside 
equivalents) 
78 - 155 - 
Ellagic acid 
(mg) 
106 - 220 - 
Phytosterols 
(mg) 
23 - 50 - 
* Strawberry composition information provided by the California Strawberry Commission 
1FDS, freeze-dried strawberries (California Strawberry Commission, CA) 
2Fiber, insoluble and soluble fiber (FiberStir, LLC, Minneapolis, MN) for low and high dose control 
beverages 
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Table 9: Baseline characteristics of the study participants1 
 
Variable Low dose FDS Low dose control High dose FDS High dose control 
n 15 15 15 15 
Age (years) 50±10 48±10 49±11 48±10 
M/F (n/n) 1/14 1/14 2/13 1/14 
Waist (inches) 41±3 43±3.2 45±5 42±2.6 
Height (cm) 165±5.8 165±6.7 164±6.5 168.5±7.6 
Weight (kg) 94.6±13.5 100±12 101±18 99±15 
BMI (kg/m2) 34.5±4.4 37±4.4 38±7 35±5 
BUN (mg/dL) 14±2.3 15.7±4.5 16±4.2 17±5 
Creatinine 
(mg/dL) 
0.8±0.2 0.8±0.2 0.8±0.2 0.9±0.3 
AST (U/L) 29±10 26±7.1 25±4.3 25±7.2 
ALT (U/L) 34±12 34±12 30±11 31±12 
WBC (K/mm3) 6.6±1.2 6.7±1.4 6.7±1.7 7.1±1.5 
RBC (M/mm3) 4.6±0.5 4.5±0.3 4.6±0.6 4.8±0.4 
Hb (g/dL) 14±1.4 13.6±1.3 14±1.4 14±1.6 
Multivitamin 
users (%) 
20.0 20.0 20.0 10.0 
Fruit servings, 
cups2 
1.2 1.0 1.2 1.0 
Vegetable 
servings, cups2 
1.0 1.1 1.1 1.2 
1Values are mean ± SD 
2Servings consumed based on diet recall at baseline 
FDS – freeze-dried strawberries; M/F – male/female; BMI – body mass index; BUN – blood urea nitrogen; 
AST – aspartate aminotransferase; ALT – alanine aminotransferase; WBC – white blood cell; K/mm3 – 
thousands per cubic milliliter; RBC – red blood cell; M/mm3 – millions per cubic milliliter; Hb - 
hemoglobin 
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Table 10: Plasma trace element levels at baseline and 12 weeks after FDS supplementation  
Group Time 
Point 
54Fe 
(mg/L) 
57Fe 
(mg/L) 
63Cu 
(mg/L) 
65Cu 
(mg/L) 
66Zn 
(mg/L) 
82Se 
(mg/L) 
Low 
dose 
FDS 
Baseline 1.0±0.4* 1.4±1.0  1.3±0.4  1.1±0.3  1.0±0.7  0.1±0.1  
Week 12 0.9±0.4 1.8±0.9  1.5±0.4  1.3±0.4  0.7±0.4  0.1±0.1  
Low 
dose 
control 
Baseline 1.7±1.8 2.5±2.4  1.5±0.5  1.3±0.4  1.4±0.9  0.2±0.1  
Week 12 0.9±0.4 1.5±0.9  1.6±0.5  1.4±0.5  0.8±0.6  0.1±0.8  
High 
dose 
FDS 
Baseline 1.0±0.4 1.3±1.2  1.9±1.1  1.6±1.1  1.0±0.4  0.1±0.1  
Week 12 1.1±0.5 1.8±1.0  1.6±0.7  1.5±0.6  0.8±0.5  0.1±0.1  
High 
dose 
control 
Baseline 0.9±0.3 1.1±0.7  1.3±0.4  1.2±0.4  0.9±0.6  0.1±0.1  
Week 12 1.2±0.8 2.0±1.3  1.6±0.4  1.4±0.4  0.9±0.7  0.1±0.1  
Footnote: Fe – iron; Cu – copper; Zn – zinc; Se – selenium; FDS - freeze-dried strawberries 
*P < 0.05 versus low dose control at baseline 
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Table 11: Plasma catalase activity levels at baseline and 12 weeks after FDS 
supplementation  
 
Intervention Group Baseline (nmol/min/mL) Week 12 (nmol/min/mL) 
Low dose FDS 38.5±39.3 13.2±4 
Low dose control 77.7±73.2 32.3±28.4 
High dose FDS 114.6±82.9* 14.6±3.3** 
High dose control 63.7±74 84.7±88.7 
 
Footnote: FDS – freeze-dried strawberries 
* P < 0.05 versus low dose FDS at baseline 
** P < 0.05 versus high dose FDS at baseline 
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Table 12: Whole blood GSH levels at baseline and 12 weeks after FDS supplementation  
 
 
Footnote: GSH - glutathione; FDS – freeze-dried strawberries 
* P < 0.05 versus low dose FDS at baseline 
** P < 0.05 versus low dose control at baseline 
*** P < 0.05 versus low dose FDS and high dose control at 12 weeks 
† P < 0.05 compared to baseline 
 
 
  
Intervention Group Baseline (µg/g Hb) Week 12 (µg/g Hb) 
Low dose FDS 1657.1±180** 2294.9±500.4 
Low dose control 1898.8±164.1 1775.3±153 
High dose FDS 1824.2±119.5* 2860.2±381.6*** 
High dose control 1789.1±199.5 1862.2±195.1 
† 
† 
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CHAPTER V 
 
 
CONCLUSION 
 
Overall findings 
To our understanding, this is the first clinical study to examine the effects of freeze-dried 
strawberries (FDS) in a dose-response manner, on trace elements and endogenous antioxidant 
markers in obese subjects with dyslipidemia. No significant effects were observed in plasma iron, 
copper, zinc, and selenium, except 54Fe which was significantly lower in low dose FDS versus 
LDC at baseline only. In the high dose FDS supplemented group, catalase activity at 12 weeks 
was significantly lower when compared with baseline values. At baseline, GSH values were 
significantly higher in high dose FDS and low dose FDS, while significantly lower in low dose 
FDS versus LDC. When compared with the fiber- and calorie-matched controls, significant 
increases in GSH were detected in both high dose FDS and low dose FDS groups after 12 weeks 
of FDS supplementation Furthermore, GSH was significantly higher in high dose FDS versus low 
dose FDS at 12-weeks.  
Trace element:  
Trace elements are critical to human health and cellular function via participation in biochemical 
reactions, as components of enzymatic structure, and also act as enzymatic cofactors8. Iron and 
copper are known to participate in oxidizing reactions which can be damaging to cells68,69,78, 
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while zinc and selenium tend to partake in antioxidant activities within cells16,74,75. Certain levels 
of iron, copper, zinc, and selenium are vital to normal bodily functions, but elevated iron and 
copper as well as decreased levels of zinc and selenium, often seen in the obese population, can 
result in an oxidant/antioxidant imbalance and lead to oxidative stress9-12,95,96.  
Populations with obesity and/or dyslipidemia are more likely to have high levels of iron and 
copper, and are also likely to have lower serum zinc and selenium levels9-12. When consumed 
with polyphenol-rich foods, iron uptake is reduced while zinc uptake may be improved as 
reported in cell culture studies167,170-172. Endogenous antioxidants and total antioxidant capacity 
are also increased in obese participants fed a polyphenol-rich food source, along with some 
studies finding alterations in trace element levels as well21,190,195,197,198. Thus, we hypothesized that 
in participants consuming high- and low-dose polyphenol-rich freeze-dried strawberries would 
demonstrate decreased serum iron and copper levels, while increased serum zinc and selenium 
levels. However, no significance was found among iron, zinc, copper, and selenium levels in our 
study subjects after 12 weeks of strawberry supplementation. Thus, we reject our hypothesis of 
predicted modulation of trace elements after low and high dose FDS supplementation. 
The forms of trace elements examined in studies must be considered in assessing outcomes.  
While we measured only free isotopes of selected elements, previous research have reported 
bound iron as well as transport proteins that play an important role in levels of these trace 
elements.99-102. Suliburska et al. found that daily consumption of green tea extract (379 mg) for 
three months reduced serum iron and zinc compared to baseline in males and females with 
obesity21. Basu et al. reported eight weeks daily consumption of green tea extract capsules 
significantly reduced plasma iron compared to baseline in men and women with obesity and 
metabolic syndrome. This study also found copper to be increased after fresh-brewed green tea 
consumption when compared to green tea extract consumption195. These findings compared with 
ours may indicate that the polyphenols found in strawberries may not significantly affect free 
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iron, zinc, copper, and selenium levels when compared to the reported effects of green tea and 
green tea extract.  However, these observations need further clarifications in larger trials on the 
effects of dietary polyphenols in circulating levels of trace elements. 
Catalase: 
Catalase is an enzyme found in the cytosol and peroxisomes of most cells and functions as an 
endogenous antioxidant by converting toxic H2O2 into water and free oxygen.  
Our study found that high dose FDS supplementation significantly lowered catalase activity at 12 
weeks compared to baseline. Therefore, we fail to reject the hypothesis that high dose FDS would 
increase catalase activity at 12 weeks compared to baseline. Since glutathione peroxidase (GPX) 
is thought to initially respond to both normal and stressful conditions where H2O2 may be 
elevated, catalase activity may have been modified in the participants from our study as a result 
of possible modified GPX activity38,128. However, we did not report GPX activity in our 
participants. Catalase activity may have also decreased as a result of increased GSH found in our 
study; GSH being the reduced form of glutathione and is readily able to donate an electron to 
reduce and stabilize ROS204. Although catalase activity was found to be decreased post-
intervention compared to baseline, this may possibly indicate improved antioxidant status as a 
result of increased GSH, which works closely with GPX as a co-enzyme and as a “first-line of 
defense” in combating increased H2O2 levels124,131. 
Our study findings are consistent with previous clinical studies which reported insignificant 
changes in catalase activity after polyphenol supplementation174,195,205-208. On the other hand, 
animal studies show different results. In rats fed a high-fat or normal diet supplemented with  
polyphenol-rich red grape skins (20 mg/kg/day) daily for four weeks, catalase activity was 
increased in both diets when compared with rats fed a high-fat or normal diet alone. Furthermore, 
catalase activity was decreased in rats fed a high-fat diet compared with a normal diet174. In 
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contrast to our findings, diabetic rats fed polyphenol-rich green tea extract for four weeks 
revealed a significant increase in catalase activity in the aorta and heart compared to the diabetic 
rat controls209. Thus, polyphenols may differ in their effects in modulating antioxidant enzyme 
systems in vivo. 
In a study by Hokayem et al. two grams per day of grape polyphenols for nine weeks showed no 
significant changes in activities of catalase, GPX, SOD, or blood GSH/GSSG ratio in overweight 
and obese adults at increased risk for type 2 diabetes205. Another study by Basu et al. showed that 
supplementation of green tea or green tea extract for eight weeks in obese subjects with metabolic 
syndrome found no significant changes in catalase activity or reduced glutathione 
concentrations195. In our study, participants with obesity and dyslipidemia supplemented in high 
doses of strawberries had decreased catalase activity post-intervention. Thus, strawberries may 
have different effects on catalase activity compared to other polyphenol-rich foods. 
Reduced glutathione (GSH):  
Reduced glutathione (GSH) is a vital cofactor for the action of GPX and decomposition of H2O2. 
In addition to decreasing H2O2, GSH also quenches singlet oxygen and regenerates vitamins C 
and E into their stable, reduced forms. In the nucleus, GSH maintains the redox balance in order 
to protect DNA from oxidative stress124,131,132.  
A dose-dependent effect was observed with the significantly higher GSH levels at 12 weeks in 
the high dose FDS compared with low dose FDS. The significantly increased levels of GSH in 
high dose compared to low dose, both low dose FDS compared with their respective controls, and 
both low and high dose FDS at 12 weeks compared to baseline may imply improved antioxidant 
status as a result of strawberry supplementation. Furthermore, we fail to reject our hypothesis that 
low and high dose FDS supplementation would increase GSH when comparing the high to low 
dose FDS, their respective dose-dependent controls, and their respective baseline levels.  
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Similar results have been reported in animal and clinical studies on the effects of fruit 
polyphenols on GSH levels. A study in mice fed a berry juice mixture of blueberry, crowberry, 
and elderberry (1:1:1) for 3-4 weeks had increased total glutathione as a result of altered γ-
glutamylcysteine synthetase (γ-GCS) following the supplementation of  the polyphenol-rich berry 
juice208. A similar study conducted by Babu et al. in diabetic rats supplemented with green tea 
extract for four weeks revealed significantly increased serum GSH content in diabetic rats 
supplemented with the polyphenol-rich extract compared with the control animals209. The 
researchers suggested that green tea directly scavenging ROS in the experimental group may have 
reduced GSH utilization, leading to an increase in GSH in rats treated with green tea extract209. 
This may also help explain our findings of significantly increased GSH in FDS supplemented 
participants. An ex vivo study examining the concentration-dependent effects of epicatechin on 
biomarkers of oxidative stress in blood samples from overweight patients with hypertension, 
found significantly increased GSH levels after supplementation of epicatechin compared to 
baseline210.  
Clinical trials have reported similar effects on GSH after polyphenol-rich supplementation. Basu 
et al. previously reported significantly increased whole blood GSH and plasma antioxidant 
capacity after eight weeks of daily green tea (4 cups) or green tea extract (two capsules, 870 mg 
catechins) supplementation compared to the controls in adults with obesity and metabolic 
syndrome. Many other studies have also reported increased total antioxidant capacity in 
participants with obesity after consuming polyphenol-rich supplements compared with their 
respective controls21,190,197,198.. 
Our findings reveal that the supplemented dosage of polyphenols (25-50 g FDS) in strawberries 
for the study duration of 12 weeks may decrease catalase activity and increase serum GSH in 
participants with obesity and dyslipidemia. No effects were noted in trace elements. Increased 
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GSH may indicate improved response to oxidative stress, though these findings warrant further 
investigation. 
Limitations 
Our study has some limitations which must be considered in the interpretation of our findings. 
Our study participants are primarily females, with five out of sixty subjects being males. Our 
study sample of sixty participants is also small. The fact that our study was confined to those with 
enlarged waist circumference and dyslipidemia, included participants who were or were not 
taking vitamin supplements, excluded participants with other chronic conditions and were 
recruited locally at the OSU and OUHSC campuses limits the generalizability of our study 
findings.  
Our study involved supplementation of freeze-dried strawberries equivalent to 1.5 – 3 cups of 
fresh strawberries per day which is much higher than the average fruit consumption in the US. 
CDC state-specific trends show only about 18% of Oklahoma residents consume two or more 
servings of fruit per day211. Thus, while our intervention may have therapeutic implications, the 
doses used may not be suitable for a preventative strategy. Also, the differences in sensory 
qualities between the strawberry and the control beverages, the latter containing vegetable fiber 
and artificial flavor and color, could have led to inadequate blinding of the participants. No diet 
analysis was performed to analyze trace element consumption of participants at baseline and at 
12-weeks. Furthermore, no comprehensive analysis was obtained from subjects to include other 
antioxidants or enzyme systems (i.e. vitamin E, GPX, SOD, etc.)  
Conclusion and recommendations 
Strawberry supplementation in our study had no significant effects on trace elements, while 
catalase activity and GSH concentrations were significantly modulated following strawberry 
supplementation. Since obesity and dyslipidemia present a condition of elevated oxidative stress 
51 
 
and compromised antioxidant function, our findings may have some implications in the 
nutritional management of these conditions.  Thus including strawberries within the 
recommended servings of fruits and vegetables, as per the Dietary Guidelines of Americans 
(2010)212, may be a prudent approach in improving the dietary sources of antioxidants in 
participants with CVD risk factors. 
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